PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome

被引:8
|
作者
Lewis, Natasha E. [1 ]
Gao, Qi [1 ]
Petrova-Drus, Kseniya [1 ,2 ]
Pulitzer, Melissa [3 ]
Sigler, Allison [1 ]
Baik, Jeeyeon [1 ]
Moskowitz, Alison J. [4 ]
Horwitz, Steven M. [4 ]
Dogan, Ahmet [1 ]
Roshal, Mikhail [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, Hematopathol Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, Diagnost Mol Pathol Serv, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, Dermatopathol Serv, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY 10065 USA
关键词
flow cytometry; mycosis fungoides; PD-1; Sezary syndrome; PROGRAMMED DEATH-1; DIFFERENTIAL EXPRESSION; T-CELLS; LYMPHOMA; CLASSIFICATION; CLONALITY; BIOPSIES; PATHWAY; MARKERS;
D O I
10.1002/cyto.b.22070
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Accurate Sezary cell detection in peripheral blood of mycosis fungoides/Sezary syndrome (MF/SS) patients by flow cytometry can be difficult due to overlapping immunophenotypes with normal T cells using standard markers. We assessed the utility of programmed death-1 (PD-1/CD279), a transmembrane protein expressed in some hematopoietic cells, for identification and quantitation of circulating Sezary cells among established markers using flow cytometry. Methods 50 MF/SS and 20 control blood samples were immunophenotyped by flow cytometry. Principal component analysis (PCA) assessed contributions of antigens to separation of abnormal from normal T cell populations. PD-1 was assessed over time in blood and bone marrow of available MF/SS cases. Results Normal CD4+ T cells showed dim/intermediate to absent PD-1 expression. PD-1 in Sezary cells was informatively brighter (>= 1/3 log) than internal normal CD4+ T cells in 39/50 (78%) cases. By PCA, PD-1 ranked 3rd behind CD7 and CD26 in population separation as a whole; it ranked in the top 3 markers in 32/50 (64%) cases and 1st in 4/50 (8%) cases when individual abnormal populations were compared to total normal CD4+ T cells. PD-1 clearly separated Sezary from normal CD4+ T cells in 15/26 (58%, 30% of total) cases with few and subtle alterations of pan-T cell antigens/CD26 and was critical in 6 (12% of total), without which identification and quantification were significantly affected or nearly impossible. PD-1 remained informative in blood/bone marrow over time in most patients. Conclusions PD-1 significantly contributes to accurate flow cytometric Sezary cell assessment in a routine Sezary panel.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 50 条
  • [41] Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sezary syndrome using T-cell receptor Vβ chain antibodies and its application in blood staging
    Feng, Bo
    Jorgensen, Jeffrey L.
    Jones, Dan
    Chen, Su S.
    Hu, Ying
    Medeiros, L. Jeffrey
    Wang, Sa A.
    MODERN PATHOLOGY, 2010, 23 (02) : 284 - 295
  • [42] Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome
    Lemchak, David
    Banerjee, Swati
    Digambar, Shaunak S.
    Hood, Brian L.
    Conrads, Thomas P.
    Jedrych, Jaroslaw
    Geskin, Larisa
    Akilov, Oleg E.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (02) : 188 - 190
  • [43] Sezary syndrome and mycosis fungoides show differential expression of programmed death-1
    Cetinozman, F.
    Jansen, P. M.
    Vermeer, M. H.
    Willemze, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S40 - S40
  • [44] Cutaneous T-Cell Lymphoma: Mycosis Fungoides/Sezary Syndrome: Part 1
    Booher, Susan
    McCann, Sue Ann
    Tawa, Marianne C.
    JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION, 2011, 3 (01) : 18 - 32
  • [45] Programmed death-1 (PD-1) Expression in Sezary Syndrome
    Wehkamp, U.
    Oschlies, I
    Brasch, J.
    Klapper, W.
    Weichenthal, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 922 - 922
  • [46] DNA CONTENT-ANALYSIS BY FLOW-CYTOMETRY AND CYTOGENETIC ANALYSIS IN MYCOSIS-FUNGOIDES AND SEZARY SYNDROME - DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS
    BUNN, PA
    WHANGPENG, J
    CARNEY, DN
    SCHLAM, ML
    KNUTSEN, T
    GAZDAR, AF
    JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (06): : 1440 - 1448
  • [48] The cytokine expression profile of mycosis fungoides and Sezary Syndrome cells after psoralen with UVA treatment
    Liszewski, W.
    Gniadecki, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S125 - S125
  • [49] MYCOSIS-FUNGOIDES AND SEZARY SYNDROME - MALIGNANT CELLS WITH T-CELL ENZYMATIC PROPERTIES
    HEWAT, B
    SIMPKINS, H
    LABORATORY INVESTIGATION, 1979, 40 (02) : 251 - 251
  • [50] International guidelines for the flow cytometric evaluation of peripheral blood for suspected Sezary syndrome or mycosis fungoides: Assay development/optimization, validation, and ongoing quality monitors
    Illingworth, Andrea
    Johansson, Ulrika
    Huang, Shuguang
    Horna, Pedro
    Wang, Sa A.
    Almeida, Julia
    Wolniak, Kristy L.
    Psarra, Katherina
    Torres, Richard
    Craig, Fiona E.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2021, 100 (02) : 156 - 182